{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:47:15Z","timestamp":1775800035850,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1136\/ard.54.9.726","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"726-729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Beh\u00e7et's disease."],"prefix":"10.1016","volume":"54","author":[{"given":"A","family":"Orem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"De\u011fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Memi\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Bahadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Ovali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Cim\u015fit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","first-page":"1152","article-title":"Uber rezidiveerende, apht6se, durch eim verus verurschte Geschwure am Mund am Ange und an den Genitalien","volume":"105","author":"Behqet, H.","year":"1937","unstructured":"Behqet H. Uber rezidiveerende, apht6se, durch eim verus verurschte Geschwure am Mund am Ange und an den Genitalien. Derm Wochenschr 1937; 105: 1152-7.","journal-title":"Derm Wochenschr"},{"key":"ref_2","first-page":"554","article-title":"Large artery involvement in Behqet's disease","volume":"14","author":"Hamza, M.","year":"1987","unstructured":"Hamza M. Large artery involvement in Behqet's disease. JRheumatol 1987; 14: 554-9.","journal-title":"JRheumatol"},{"key":"ref_3","first-page":"423","article-title":"Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behcet's disease","volume":"25","author":"Kluft, C.; J, Michiels J.; Wijngaards, G.","year":"1980","unstructured":"Kluft C, Michiels J J, Wijngaards G. Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behcet's disease. Scand Haematol 1980; 25: 423-30.","journal-title":"Scand Haematol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0190-9622(90)70179-L","article-title":"Superfacial thrombophelbitis II. Secondary hypercoagulable states","volume":"23","author":"P, Samloska C.; D, James W.","year":"1990","unstructured":"Samloska C P, James W D. Superfacial thrombophelbitis II. Secondary hypercoagulable states. Am Acad Dermatol 1990; 23: 1-18.","journal-title":"Am Acad Dermatol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0049-3848(84)90384-0","article-title":"Evidence for endothelial cell dysfunction in association with Behqet's disease","volume":"34","author":"Schimitz-Huebner, U.; Knob, J.","year":"1984","unstructured":"Schimitz-Huebner U, Knob J. Evidence for endothelial cell dysfunction in association with Behqet's disease. Thromb Res 1984; 34: 277-85.","journal-title":"Thromb Res"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0038-1646409","article-title":"Coagulation and fibrinolytic activity in Beheet's disease","volume":"66","author":"K, Hampton K.; A, Chamberlain M.; K, Menon D.; A, Davies J.","year":"1991","unstructured":"Hampton K K, Chamberlain M A, Menon D K, Davies J A. Coagulation and fibrinolytic activity in Beheet's disease. Thromb Haemost 1991; 66: 292-4.","journal-title":"Thromb Haemost"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.48.7.590","article-title":"Defective fibrinolysis in Behcet's syndrome: significance and possible mechanism","volume":"48","author":"Aitchison, R.; Chu, P.; R, Cater D.; Harris, J.; J, Powell R.","year":"1989","unstructured":"Aitchison R, Chu P, Cater D R, Harris J, Powell R J. Defective fibrinolysis in Behcet's syndrome: significance and possible mechanism. Ann Rheum Dis 1989; 48: 590-3.","journal-title":"Ann Rheum Dis"},{"key":"ref_8","first-page":"935","article-title":"Plasminogen activator activity levels in patients with Behqet's syndrome","volume":"105","author":"Mishima, H.; Masuda, K.; Shimada, S.; Toki, N.; Tsushima, H.; Gocho, M.","year":"1985","unstructured":"Mishima H, Masuda K, Shimada S, Toki N, Tsushima H, Gocho M. Plasminogen activator activity levels in patients with Behqet's syndrome. Arch Ophthalmol 1985; 105: 935-6.","journal-title":"Arch Ophthalmol"},{"key":"ref_9","first-page":"1705","article-title":"Lipoprotein (a): heterogeneity and biological relevance","volume":"85","author":"M, Scanu A.; M, Fless G.","year":"1990","unstructured":"Scanu A M, Fless G M. Lipoprotein (a): heterogeneity and biological relevance. Clin Invest 1990; 85: 1705-15.","journal-title":"Clin Invest"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0021-9150(91)90052-5","article-title":"Does lipoprotein(a) [Lp(a)] compete with plasminogen in human atherosclerotic lesions and thrombi?","volume":"89","author":"B, Smith E.; L, Crosbie","year":"1991","unstructured":"Smith E B, Crosbie L. Does lipoprotein(a) [Lp(a)] compete with plasminogen in human atherosclerotic lesions and thrombi? Atherosclerosis 1991; 89: 127-36.","journal-title":"Atherosclerosis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0038-1645041","article-title":"interloper into fibrinolytic system?","volume":"63","author":"A, Miles L.","year":"1990","unstructured":"Miles L A, Plow E F. Lp(a): an interloper into fibrinolytic system? Thromb Haemost 1990; 63: 331-5.","journal-title":"Thromb Haemost"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0026-0495(75)90098-0","article-title":"Lp(a) lipoproteins: relationship to sinking pre-beta lipoprotein, hyperlipoproteinemia and apolipoprotein B","volume":"24","author":"J, Albers J.; G, Cabana V.; R, Wernick G.; R, Hazzard W.","year":"1975","unstructured":"Albers J J, Cabana V G, Wernick G R, Hazzard W R. Lp(a) lipoproteins: relationship to sinking pre-beta lipoprotein, hyperlipoproteinemia and apolipoprotein B. Metabolism 1975; 24: 1047-52.","journal-title":"Metabolism"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/BF01745519","article-title":"Serum lipoprotein(a) concentrations are not influenced by an HMG-Coa reductase inhibitor","volume":"66","author":"Thiery, J.; M, Armstrong V.; Schleef, J.; Creutzfeldt, C.; Creultzfelt, W.; Seidel, D.","year":"1988","unstructured":"Thiery J, Armstrong V M, Schleef J, Creutzfeldt C, Creultzfelt W, Seidel D. Serum lipoprotein(a) concentrations are not influenced by an HMG-Coa reductase inhibitor. Kin Wochenschr 1988; 66: 462-7.","journal-title":"Kin Wochenschr"},{"key":"ref_14","first-page":"145","article-title":"Transient change of serum lipoprotein(a) as an acute phase protein","volume":"78","author":"Maeda, S.; Abe, A.; Seishima, M.; Makino, K.; Noma, A.; Kawade, M.","year":"1987","unstructured":"Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient change of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 1987; 78: 145-50.","journal-title":"Atherosclerosis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/00365519209088771","article-title":"Lipoprotein(a) and acute phase proteins in acute myocardial infarction","volume":"52","year":"1992","unstructured":"Shinga L, Johonson 0, Dahlen G H, Eriksson S. Lipoprotein(a) and acute phase proteins in acute myocardial infarction. Scand Jf Clin Lab Invest 1992; 52: 95-101.","journal-title":"Scand Jf Clin Lab Invest"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.50.6.366","article-title":"Lipoprotein(a), lipids and lipoproteins in patients with rheumatoid arthritis","volume":"50","author":"Rantapaa-Dahlqvist, S.; Wallberg-Jonsson, S.; Dahlen, G.","year":"1991","unstructured":"Rantapaa-Dahlqvist S, Wallberg-Jonsson S, Dahlen G. Lipoprotein(a), lipids and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 1991; 50: 366-8.","journal-title":"Ann Rheum Dis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ijc.2910430212","article-title":"Elevated apolipoprotein(a) levels in cancer patients","volume":"43","author":"C, Wright L.; R, Sullivan D.; M, Muller; M, Dyne; N, Tattersall M.H.; E, Mountfold C.","year":"1989","unstructured":"Wright L C, Sullivan D R, Muller M, Dyne M, Tattersall M H N, Mountfold C E. Elevated apolipoprotein(a) levels in cancer patients. Intl Cancer 1989; 43: 241-4.","journal-title":"Intl Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/339301a0","article-title":"A potential basis for the thrombotic risks associated with lipoprotein(a)","volume":"339","author":"A, Miles L.","year":"1989","unstructured":"Miles L A, Fless G M, Levin E G, Scanu A M, Plow E F. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature 1989; 339: 301-3.","journal-title":"Nature"},{"key":"ref_19","first-page":"373","article-title":"Biology of Disease. Lipoprotein(a) and its role in atherothrombotic disease","volume":"64","author":"C, Howard G.; V, Pizzo S.","year":"1994","unstructured":"Howard G C, Pizzo S V. Biology of Disease. Lipoprotein(a) and its role in atherothrombotic disease. Lab Invest 1994; 64: 373-85.","journal-title":"Lab Invest"},{"key":"ref_20","first-page":"351","article-title":"Deger 0, Memis 0","volume":"53","author":"Orem, A.","year":"1994","unstructured":"Orem A, Deger 0, Memis 0, Cah$kan K, Cimsit G. High lipoprotein(a) levels as a thrombogenic risk factor in Behcet's disease. Ann Rheum Dis 1994; 53: 351-2.","journal-title":"Ann Rheum Dis; High lipoprotein(a) levels as a thrombogenic risk factor in Behcet's disease"},{"key":"ref_21","first-page":"1078","article-title":"Study Group for Behqet's Disease: criteria for diagnosis of Behcet's disease","volume":"335","author":"International","year":"1990","unstructured":"International Study Group for Behqet's Disease: criteria for diagnosis of Behcet's disease. Lancet 1990; 335: 1078-80.","journal-title":"Lancet"},{"key":"ref_22","first-page":"499","article-title":"Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge","volume":"8","author":"T, Fridewald W.; I, Levy R.; S, Frederickson D.","year":"1972","unstructured":"Fridewald W T, Levy R I, Frederickson D S. Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 8: 499-502.","journal-title":"Clin Chem"},{"key":"ref_23","first-page":"127","article-title":"Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role","volume":"113","author":"M, Scanu A.","year":"1992","unstructured":"Scanu A M. Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role. Mol Cell Biochem 1992; 113: 127-31.","journal-title":"Mol Cell Biochem"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/339303a0","article-title":"Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis","volume":"339","year":"1989","unstructured":"Hajjar K A, Gavish 0, Breslow J L, Nachman R L. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303-5.","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1021\/bi00432a005","article-title":"Further characterisation of cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein(a) compete for the same site","volume":"28","author":"Gonzales-Gronow, M.; M, Edelberg J.; V, Pizzo S.","year":"1989","unstructured":"Gonzales-Gronow M, Edelberg J M, Pizzo S V. Further characterisation of cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein(a) compete for the same site. Biochemistry 1989; 28: 2374-7.","journal-title":"Biochemistry"},{"key":"ref_26","first-page":"2459","article-title":"Lipoprotein(a) regulates plasminogen activator inhibitor-I expression in endothelial cell","volume":"226","year":"1991","unstructured":"Etingin 0 R, Hajjar D P, Hajjar K A, Harpel P C, Nachman R L. Lipoprotein(a) regulates plasminogen activator inhibitor-I expression in endothelial cell. J Biol Chem 1991; 226: 2459-65.","journal-title":"J Biol Chem"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0049-3848(92)90080-T","article-title":"Does Lp(a) lipoprotein inhibit the fibrinolytic system?","volume":"68","year":"1992","unstructured":"Halvorsen S, Skjonsberg 0 H, Berg K, Ruyter R, Godal H C. Does Lp(a) lipoprotein inhibit the fibrinolytic system? Thromb Res 1992; 68: 223-32.","journal-title":"Thromb Res"},{"key":"ref_28","series-title":"Fibrinolysis","first-page":"16","article-title":"The effect of recombinant apolipoprotein(a) on in-vitro fibrinolysis","volume":"4","author":"L, Eaton D.; F.","year":"1990","unstructured":"Eaton D L, Tohmlinson J E, Higgins D H, Koschinsk M L, Lawn D L, Zioncheck T F. The effect of recombinant apolipoprotein(a) on in-vitro fibrinolysis. Fibrinolysis 1990;4: 16."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/000456329403100406","article-title":"Distribution of plasma lipoprotein(a) levels in a healthy Turkish population","volume":"31","year":"1994","unstructured":"Orem A, Deger 0, Onder E, Karahan S C, Efe H, Uzunosmanoglu D. Distribution of plasma lipoprotein(a) levels in a healthy Turkish population. Ann Clin Biochem 1994;31:343-6.","journal-title":"Ann Clin Biochem"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0009-9120(94)00078-A","article-title":"Evaluation of lipoprotein(a) [Lp(a)] as a risk factor for coronary artery disease in the Turkish population","volume":"28","year":"1995","unstructured":"Orem A, Deger 0, Kulan K, Onder E, Kiran E, Uzunosmanoglu D. Evaluation of lipoprotein(a) [Lp(a)] as a risk factor for coronary artery disease in the Turkish population. Clin Biochem 1995; 28: 171-3.","journal-title":"Clin Biochem"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0026-0495(93)90042-M","article-title":"Relationship between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer","volume":"42","author":"J, Glueck C.; I, Glueck H.; T, Tracy; J, Speirs; C, McGray; D, Stoop","year":"1993","unstructured":"Glueck C J, Glueck H I, Tracy T, Speirs J, McGray C, Stoop D. Relationship between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer. Metabolism 1993; 42: 236-46.","journal-title":"Metabolism"},{"key":"ref_32","article-title":"Increase of Lp(a) lipoprotein among population","author":"G, Dahlen H.","year":"1990","unstructured":"Dahlen H G. Increase of Lp(a) lipoprotein among population. In: Scanu AM, ed. Lipoprotein (a). San Diego: Academic Press Inc, 1990; 151-71."},{"key":"ref_33","article-title":"Coagulation and fibrinolysis in 70 patients with Behret's disease","volume-title":"Recent advances in Behlet's disease","author":"Lehner, T.","year":"1986","unstructured":"Conard J, Harellou M H, Wechsler B, Bletry 0, Godeau P, Samama M. Coagulation and fibrinolysis in 70 patients with Behret's disease. In: Lehner T, Barners C G, eds. Recent advances in Behlet's disease. London: Royal Society of Medicine Services, 1986; 161."},{"key":"ref_34","first-page":"417","article-title":"Fibrinogen and atherosclerosis","volume":"105","author":"B, Smith E.","year":"1993","unstructured":"Smith E B. Fibrinogen and atherosclerosis. Wien Klin Wochenschr 1993; 105: 417-27.","journal-title":"Wien Klin Wochenschr"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724030346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724030346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.54.9.726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T06:07:46Z","timestamp":1737439666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724030346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["S0003496724030346"],"URL":"https:\/\/doi.org\/10.1136\/ard.54.9.726","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1995,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Beh\u00e7et's disease.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.54.9.726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1995 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}